ОРГАНИЗАЦИЯ ФАРМАЦЕВТИЧЕСКОГО КОНСУЛЬТИРОВАНИЯ ПАЦИЕНТОВ С АЛЛЕРГИЧЕСКИМ РИНИТОМ
Ключевые слова:
фармацевтическое консультирование, аллергический ринит, антигистаминные препаратыАннотация
В данной статье приводятся результаты характеристики особенностей
фармацевтического консультирования посетителей аптек с аллергическим ринитом при
применении антигистаминных препаратов. Предмет исследования – аллергический ринит,
перечень лекарственных средств, реализуемых без рецепта врача, Государственный реестр
лекарственных средств ДЛС и МИ при МЗ КР, инструкции по медицинскому применению
ЛС. Анализ ассортимента проводили по критериям: анатомо-терапевтическо-химическая
(АТХ) классификация, международное непатентованное наименование (МНН), торговое
наименование, состав, лекарственная форма, производитель, показания и противопоказания
к применению. Методы исследования: эмпирические (сравнения, группировки, контент-анализ), комплекснокомбинированные (анализ и синтез).
Библиографические ссылки
George PP, Molina JAD, Cheah J, Chan SC, Lim B. P. The evolving role of the community pharmacist in chronic disease management—a literature review. Ann Acad Med Singapore.
;39(11):861–7.
Goode JV, Owen J, Page A, Gatewood S. Community-based pharmacy practice innovation
and the role of the community-based pharmacist practitioner in the United States. Pharm J Pharm
Educ Pract. 2019;7(3):106.
Joseph Moose P, Ashley Branham P. Pharmacists as influencers of patient adherence.
Pharm Times Oncol Ed. 2014;1(5).
Tsuyuki R.T, Johnson J.A, Teo K.K, Simpson S.H, Ackman M.L, Biggs R.S, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med.
;162(10):1149–55.
Daly C.J, Quinn B, Mak A, Jacobs D.M. Community pharmacists’ perceptions of patient
care services within an enhanced service network. Pharmacy. 2020;8(3):172.
Alfadl A.A, Alrasheedy A.A, Alhassun M.S. Evaluation of medication counseling practice at
community pharmacies in Qassim region, Saudi Arabia. Saudi Pharm J SPJ. 2018;26(2):258–62.
Qudah B, Thakur T, Chewning B. Factors influencing patient participation in medication counseling at the community pharmacy: a systematic review. Res Soc Adm Pharm.
;17(11):1863–76.
Pawankar R. Allergic diseases and asthma: a global public health concern and a call to
action. World Allergy Organ J. (2014) 7:12.
Licari A, Manti S, Ciprandi G. What are the effects of rhinitis on patients with asthma?
Expert Rev Respir Med. (2019) 13:503–5.
Steelant B, Farre R, Wawrzyniak P, Belmans J, Dekimpe E, Vanheel H, et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. J Allergy Clin Immunol. (2016) 137:1043–53.
Steelant B, Seys S.F, Van Gerven L, Van Woensel M, Farre R, Wawrzyniak P, et al. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. J Allergy Clin
Immunol. (2018) 141:951–63.
Nur Husna SM, Tan H-TT, Md Shukri N, Mohd Ashari NS, Wong KK. Nasal epithelial barrier integrity and tight junctions disruption in allergic rhinitis: overview and pathogenic insights.
Front Immunol. (2021) 12:663626.
Siti Sarah COS, Shukri N.M, Ashari NSM, Wong K.K. Zonula occludens and nasal epithelial barrier integrity in allergic rhinitis. PeerJ. (2020) 8:e9834.
Brozek J.L, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol.
(2017) 140:950–8.
D’Amato G, Akdis C. Global warming, climate change, air pollution and allergies. Allergy.
(2020) 75:2158–60.
Campo P, Rondón C, Gould H.J, Barrionuevo E, Gevaert P, Blanca M. Local IgE in non-allergic rhinitis. Clin Exp Allergy. 2015;45(5):872–881.
Campo P, Salas M, Blanca-López N, Rondón C. Local allergic rhinitis. Immunol Allergy
Clin North Am. 2016;36(2):321–332.
Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2018 Sep
;14(Suppl 2):51.
Bergmann KC, Buters J, Karatzas K, Tasioulis T, Werchan B, Werchan M, et al. The development of birch pollen seasons over 30 years in Munich, Germany—an EAACI task force report.
Allergy. (2020) 75:3024–6.
Hisinger-Molkanen H, Piirila P, Haahtela T, Sovijarvi A, Pallasaho P. Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis. World
Allergy Organ J. (2018) 11:6.
Singh S, Sharma BB, Salvi S, Chhatwal J, Jain KC, Kumar L, et al. Allergic rhinitis, rhinoconjunctivitis, and eczema: prevalence and associated factors in children. Clin Respir J. (2018)
:547–56.
Chung S.J, Kim B.K, Oh J.H, Shim J.S, Chang Y.S, Cho S.H, et al. Novel tobacco products
including electronic cigarette and heated tobacco products increase risk of allergic rhinitis and
asthma in adolescents: analysis of Korean youth survey. Allergy. (2020) 75:1640–8.
Church M.K, Church D.S. Pharmacology of antihistamines. Indian J Dermatol. (2013)
:219.
Hossenbaccus L, Linton S, Garvey S, Ellis A.K. Towards definitive management of allergic
rhinitis: best use of new and established therapies. Allergy Asthma Clin Immunol. (2020) 16:1–17.
Этический кодекс фармацевта Кыргызской Республики [Электронный ресурс]. Департамент лекарственных средств и медицинских изделий при Министерстве здравоохранения КР. – Режим доступа: http://www. http://www.pharm.kg/ru/ethical_code/. Загл. с экрана.
